Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

New understanding and treatments for hair loss are improving, but more research is needed.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Women are more likely to have long-term post-COVID symptoms than men.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

New techniques have improved acne scar treatment, but multiple tailored sessions are often needed.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Overexpression of SSAT in mice causes hair loss, liver damage, and sensitivity to polyamine analogues.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Finasteride can cause serious side effects in some men, needing more research for treatment.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Over 25% of COVID-19 patients had symptoms lasting more than a year.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

An unhealthy scalp can damage new hair, but using ZPT shampoo can improve hair health.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.